Secondhand smoke exposure avoidance

Avoid

2 studies · 1 recommendation

Last updated: February 25, 2026

Secondhand smoke exposure avoidance – Lung Cancer

Avoid2 studies

Avoiding secondhand smoke significantly reduces lung cancer risk, especially small cell carcinoma

A pooled analysis of 18 case-control studies (2,504 never-smoking lung cancer cases and 7,276 controls) from the International Lung Cancer Consortium found that secondhand smoke exposure increases overall lung cancer risk by 31% (OR 1.31, 95% CI: 1.17–1.45). The association is particularly strong for small cell lung cancer (OR 3.09, 95% CI: 1.62–5.89), over twice the risk seen in non-small cell cancers. Adenocarcinoma risk rises 26% with exposure, and clear dose–response relationships exist with both duration and intensity. A UK Biobank cohort study of 424,407 adults further confirmed that separating never-smokers by secondhand smoke exposure status reveals distinct risk profiles, with ETS-exposed individuals facing elevated lung cancer incidence over 7 years of follow-up.

Evidence

White blood cell count and risk of incident lung cancer in the UK Biobank

Authors: Bassig, BA, Chanock, SJ, Elliott, P, Freedman, ND, Hu, W, Ji, B-T, Lan, Q, Loftfield, E, Rothman, N, Silverman, DT, Wong, JYY

Published: December 4, 2019

Among never-smoking women without environmental tobacco smoke (ETS) exposure (108 cases among 111,294 participants), those in the highest WBC quartile still had significantly elevated lung cancer risk (HR=1.93, 95% CI: 1.11-3.35), indicating that inflammatory pathways contribute to lung cancer risk independent of smoking. The study design specifically separated never-smokers by ETS exposure status in this cohort of 424,407 UK Biobank adults followed for 7 years. The persistent association in ETS-unexposed never-smokers highlights that while avoiding secondhand smoke is important, elevated WBC-associated inflammation represents an independent risk pathway for lung cancer development.

View Source →

Exposure to secondhand tobacco smoke and lung cancer by histological type: A pooled analysis of the International Lung Cancer Consortium (ILCCO)

Authors: Andrew, Angeline S., Bencko, Vladimir, Boffetta, Paolo, Brennan, Paul, Chang, Shen‐chih, Chen, Ying, Christiani, David C., Cote, Michele L., Duell, Eric J., Fabianova, Eleonora, Field, John K., Foretova, Lenka, Holcatova, Ivana, Hong, Yun‐chul, Hung, Rayjean J., Janout, Vladimir, Kim, Claire H., Kim, Jin Hee, Kiyohara, Chikako, Lazarus, Philip, Le Marchand, Loic, Lee, Yuan‐chin Amy, Liloglou, Triantafillos, Lim, Wei‐yen, Lissowska, Jolanta, Mates, Dana, Matsuo, Keitaro, McLaughlin, John R., McNallan, Sheila R., Morgenstern, Hal, Mukeria, Anush, Neri, Monica, Onega, Tracy, Rudnai, Peter, Schwartz, Ann G., Seow, Adeline, Szeszenia‐dabrowska, Neonila, Tajima, Kazuo, Ugolini, Donatella, Vineis, Paolo, Yang, Ping, Zaridze, David, Zhang, Zuo‐feng

Published: January 1, 2014

Pooled analysis of 18 case-control studies from the International Lung Cancer Consortium including 2,504 never-smoking lung cancer cases and 7,276 never-smoking controls. Ever-exposure to secondhand smoke yielded an overall OR of 1.31 (95% CI: 1.17–1.45) for all lung cancer types combined. By histological subtype: adenocarcinoma OR 1.26 (95% CI: 1.10–1.44), squamous cell carcinoma OR 1.41 (95% CI: 0.99–1.99), large cell OR 1.48 (95% CI: 0.89–2.45), and small cell lung cancer OR 3.09 (95% CI: 1.62–5.89). Small cell lung cancer showed a significantly stronger association than nonsmall cell cancers (ratio of odds ratios 2.11, 95% CI: 1.11–4.04). Dose–response relationships were observed with both duration and intensity of exposure.

View Source →